DK62692D0 - - Google Patents
Info
- Publication number
- DK62692D0 DK62692D0 DK92626A DK62692A DK62692D0 DK 62692 D0 DK62692 D0 DK 62692D0 DK 92626 A DK92626 A DK 92626A DK 62692 A DK62692 A DK 62692A DK 62692 D0 DK62692 D0 DK 62692D0
- Authority
- DK
- Denmark
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK92626A DK62692D0 (lv) | 1992-05-14 | 1992-05-14 | |
| IL105673A IL105673A (en) | 1992-05-14 | 1993-05-11 | Use of n-substituted adenosine derivatives for the preparation of medicaments for treating myocardial or cerebral ischemia, certain novel n-substituted adenosine derivatives and pharmaceutical compositions containing them |
| AU40612/93A AU671995B2 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
| NZ252110A NZ252110A (en) | 1992-05-14 | 1993-05-12 | Adenosine derivatives and pharmaceutical compositions |
| PCT/DK1993/000158 WO1993023418A1 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
| EP93909822A EP0603348A1 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
| JP5519787A JPH06508855A (ja) | 1992-05-14 | 1993-05-12 | プリン誘導体 |
| CA002113547A CA2113547A1 (en) | 1992-05-14 | 1993-05-12 | Purine derivatives |
| FI940167A FI940167A (fi) | 1992-05-14 | 1994-01-13 | Puriinijohdannaisia |
| NO940123A NO940123L (no) | 1992-05-14 | 1994-01-13 | Purinderivater |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK92626A DK62692D0 (lv) | 1992-05-14 | 1992-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK62692D0 true DK62692D0 (lv) | 1992-05-14 |
Family
ID=8095717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92626A DK62692D0 (lv) | 1992-05-14 | 1992-05-14 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0603348A1 (lv) |
| JP (1) | JPH06508855A (lv) |
| AU (1) | AU671995B2 (lv) |
| CA (1) | CA2113547A1 (lv) |
| DK (1) | DK62692D0 (lv) |
| FI (1) | FI940167A (lv) |
| IL (1) | IL105673A (lv) |
| NZ (1) | NZ252110A (lv) |
| WO (1) | WO1993023418A1 (lv) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK155292D0 (da) * | 1992-12-23 | 1992-12-23 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| PL316985A1 (en) * | 1994-05-10 | 1997-03-03 | Sandoz Ltd | Derivatives of adenosine |
| EP0704215A3 (en) * | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibitor of vascular permeability enhancer |
| GB9421133D0 (en) * | 1994-10-20 | 1994-12-07 | Glaxo Group Ltd | Medicaments |
| US6110902A (en) * | 1997-06-23 | 2000-08-29 | Moehler; Hanns | Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
| US6803457B1 (en) | 1999-09-30 | 2004-10-12 | Pfizer, Inc. | Compounds for the treatment of ischemia |
| CO5180581A1 (es) * | 1999-09-30 | 2002-07-30 | Pfizer Prod Inc | Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia |
| AU2001260076A1 (en) * | 2000-05-15 | 2001-11-26 | Novo-Nordisk A/S | Compounds for treating disorders where a decreased level of plasma ffa is desired |
| US7414036B2 (en) | 2002-01-25 | 2008-08-19 | Muscagen Limited | Compounds useful as A3 adenosine receptor agonists |
| WO2007107598A1 (en) | 2006-03-21 | 2007-09-27 | Heinrich-Heine-Universität Düsseldorf | Phosphorylated a2a receptor agonists |
| CZ2009298A3 (cs) * | 2009-05-14 | 2010-11-24 | Univerzita Palackého v Olomouci | Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující |
| SI2523669T1 (sl) | 2010-01-11 | 2017-05-31 | Inotek Pharmaceuticals Corporation | Kombinacija, komplet in metoda za zmanjšanje intraokularnega tlaka |
| WO2011119969A1 (en) | 2010-03-26 | 2011-09-29 | Inotek Pharmaceuticals Corporation | Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
| JP2013523738A (ja) * | 2010-03-26 | 2013-06-17 | イノテック ファーマシューティカルズ コーポレイション | アデノシン化合物およびそれらの使用 |
| DK2807178T3 (en) | 2012-01-26 | 2017-09-04 | Inotek Pharmaceuticals Corp | Anhydrous polymorphs of (2R, 3S, 4R, 5R) -5- (6- (cyclopentylamino) -9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl nitrate and processes for their preparation |
| SG11201506882YA (en) | 2013-03-15 | 2015-09-29 | Inotek Pharmaceuticals Corp | Ophthalmic formulations |
| JP2015172077A (ja) * | 2015-06-24 | 2015-10-01 | 中国医学科学院葯物研究所 | Ｎ６−置換アデノシン誘導体とｎ６−置換アデニン誘導体の鎮静、催眠、抗うつ、抗痙攣、抗てんかん、抗パーキンソン病と認知証予防・治療の用途 |
| GB2582361A (en) * | 2019-03-21 | 2020-09-23 | Univ Warwick | Adenosine receptor agonists |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL128629C (lv) * | 1966-05-07 | |||
| DE1670077C3 (de) * | 1966-05-07 | 1975-04-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Adenosin-Derivate und Verfahren zu ihrer Herstellung |
| NL6717061A (lv) * | 1966-12-21 | 1968-06-24 | ||
| DE2052596A1 (de) * | 1970-10-27 | 1972-05-04 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten |
| DE3406533A1 (de) * | 1984-02-23 | 1985-08-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten |
| WO1985004882A1 (en) * | 1984-04-18 | 1985-11-07 | Nelson Research And Development Company | N-6 substituted adenosine derivatives as cardiac vasodilators |
| US4791103A (en) * | 1985-02-08 | 1988-12-13 | Warner-Lambert Company | 2,N6 -disubstituted adenosines, derivatives and methods of use |
| JPH0696534B2 (ja) * | 1986-04-25 | 1994-11-30 | ヘキストジヤパン株式会社 | 抗痴呆剤 |
| GB8729994D0 (en) * | 1987-12-23 | 1988-02-03 | Glaxo Group Ltd | Chemical compounds |
| HUT61567A (en) * | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
| DK62592D0 (lv) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As |
-
1992
- 1992-05-14 DK DK92626A patent/DK62692D0/da unknown
-
1993
- 1993-05-11 IL IL105673A patent/IL105673A/en not_active IP Right Cessation
- 1993-05-12 WO PCT/DK1993/000158 patent/WO1993023418A1/en not_active Application Discontinuation
- 1993-05-12 AU AU40612/93A patent/AU671995B2/en not_active Ceased
- 1993-05-12 EP EP93909822A patent/EP0603348A1/en not_active Withdrawn
- 1993-05-12 JP JP5519787A patent/JPH06508855A/ja active Pending
- 1993-05-12 NZ NZ252110A patent/NZ252110A/en unknown
- 1993-05-12 CA CA002113547A patent/CA2113547A1/en not_active Abandoned
-
1994
- 1994-01-13 FI FI940167A patent/FI940167A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI940167A (fi) | 1994-03-03 |
| JPH06508855A (ja) | 1994-10-06 |
| NZ252110A (en) | 1996-07-26 |
| FI940167A0 (fi) | 1994-01-13 |
| WO1993023418A1 (en) | 1993-11-25 |
| EP0603348A1 (en) | 1994-06-29 |
| AU4061293A (en) | 1993-12-13 |
| IL105673A (en) | 1998-01-04 |
| CA2113547A1 (en) | 1993-11-25 |
| IL105673A0 (en) | 1993-09-22 |
| AU671995B2 (en) | 1996-09-19 |